These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2803482)
1. Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain. McKenna DJ; Nazarali AJ; Himeno A; Saavedra JM Neuropsychopharmacology; 1989 Mar; 2(1):81-7. PubMed ID: 2803482 [TBL] [Abstract][Full Text] [Related]
2. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Pranzatelli MR Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895 [TBL] [Abstract][Full Text] [Related]
3. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes. Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696 [TBL] [Abstract][Full Text] [Related]
4. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin. McKenna DJ; Peroutka SJ J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353 [TBL] [Abstract][Full Text] [Related]
6. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation. Chaouloff F; Baudrie V; Coupry I Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013 [TBL] [Abstract][Full Text] [Related]
7. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis. Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289 [TBL] [Abstract][Full Text] [Related]
9. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. Marek GJ; Aghajanian GK J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525 [TBL] [Abstract][Full Text] [Related]
12. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors. Lyon RA; Davis KH; Titeler M Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649 [TBL] [Abstract][Full Text] [Related]
13. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells. Ferry RC; Unsworth CD; Molinoff PB Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988 [TBL] [Abstract][Full Text] [Related]
14. Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist. Rinaldi-Carmona M; Prabonnaud V; Bouaboula M; Poinot-Chazel C; Casellas P; Le Fur G; Herbert JM J Biol Chem; 1994 Jan; 269(1):396-401. PubMed ID: 8276825 [TBL] [Abstract][Full Text] [Related]
15. Human platelet [125I]R-DOI binding sites. Characterization by in vitro autoradiography. Himeno A; Saavedra JM Neuropsychopharmacology; 1990 Feb; 3(1):25-32. PubMed ID: 2306333 [TBL] [Abstract][Full Text] [Related]
16. Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain. Rahimian R; Hrdina PD Can J Physiol Pharmacol; 1995 Dec; 73(12):1686-91. PubMed ID: 8834481 [TBL] [Abstract][Full Text] [Related]
17. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Shannon M; Battaglia G; Glennon RA; Titeler M Eur J Pharmacol; 1984 Jun; 102(1):23-9. PubMed ID: 6479216 [TBL] [Abstract][Full Text] [Related]
18. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment. Leysen JE; Janssen PF; Niemegeers CJ Eur J Pharmacol; 1989 Apr; 163(1):145-9. PubMed ID: 2545460 [TBL] [Abstract][Full Text] [Related]
19. DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities. Cohen ML; Johnson MP; Schenck KW; Susemichel A; Wainscott DB; Robertson DW; Nelson DL J Pharmacol Exp Ther; 1993 Aug; 266(2):943-9. PubMed ID: 8355216 [TBL] [Abstract][Full Text] [Related]
20. 5-HT2 receptors, roles and regulation. Leysen JE; Pauwels PJ Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]